GeeLark Expands Its AIGC Suite and Opens AI Content Creation to Free Users
SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- GeeLark today announced a major expansion of its AIGC capabilities, introducing new AI models and editing tools for social media content creation. Previously available only to paid users, GeeLark AIGC can now...
Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers
TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. TAIPEI, Aug. 28, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWSE: 6838), today announced the...
HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation
Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities The partnership unites global clinical operations excellence with advanced digital twin technology, delivering simulation-first drug...
Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma
SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion...
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and...
Why Helsinki Should Be on Every Art Lover's Travel List in Summer 2027
HELSINKI, Aug. 28, 2026 /PRNewswire/ -- Following a record-breaking edition that attracted more than half a million visits, Helsinki Biennial returns in summer 2027, inviting visitors to discover world-class contemporary art across the historic...
Lasfit Expands Its Vehicle-Specific Ford F-150 Upgrade Solutions Across Lighting, Protection and Outdoor Use
LOS ANGELES, Aug. 28, 2026 /PRNewswire/ -- Lasfit has rolled out brand-new LED ditch lights tailored for Ford F-150 off-road and outdoor adventures, further enriching its dedicated product ecosystem for the iconic pickup truck. This new launch adds...
InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation
NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical...